Clinical Trial: Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer (GeparSixto)

Sponsor and Collaborators
German Breast Group, Cephalon, Roche Pharma AG, GlaxoSmithKline

Principal Investigator
Gunter von Minckwitz, MD, Prof, ASCO, AACR, ESMO, DKG, DGGG, AGO, DGS, BIG, BCIRG, St. Gallen Consensus Panel


Continue Reading

ClinicalTrials.gov Identifier

NCT01426880